Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
Methods of Medium Optimization01:28

Methods of Medium Optimization

Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Fatality Rate of Patients with Acute Myocardial Infarction in 253 Chest Pain Centers - China, 2019-2020.

China CDC weekly·2022
Same author

DESSO-DB: A web database for sequence and shape motif analyses and identification.

Computational and structural biotechnology journal·2022
Same author

Immunostaining of phospho-RIPK3 in L929 cells, murine yolk sacs, ceca, and small intestines.

STAR protocols·2022
Same author

Gram-negative multidrug-resistant organisms were dominant in neurorehabilitation ward patients in a general hospital in southwest China.

Scientific reports·2022
Same author

Construction of a four-mRNA prognostic signature with its ceRNA network in CESC.

Scientific reports·2022
Same author

PhenoDEF: a corpus for annotating sentences with information of phenotype definitions in biomedical literature.

Journal of biomedical semantics·2022
Same journal

Optimizing Subcutaneous Antibody Dosing Regimens Through Operating Space Maps: rHuPH20 Case Study.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Mechanistic modeling of FcRn-dependent IgG drug interactions: Clinical applications and dosing implications.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Comparing heavy-tailed residual error models for outlier handling in population PK modeling.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Personalized prophylactic therapy optimization in hemophilia A using a hybrid PK-PD-TTE model and deep RL.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Pediatric oral cavity physiologically based pharmacokinetic model to predict pharmacokinetics of mucoadhesive atropine gel to treat sialorrhea.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Exposure-safety analyses of talazoparib in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) in the TALAPRO-2 trial.

Journal of pharmacokinetics and pharmacodynamics·2026
See all related articles

Related Experiment Videos

A novel global search algorithm for nonlinear mixed-effects models using particle swarm optimization.

Seongho Kim1, Lang Li

  • 1Department of Bioinformatics and Biostatistics, School of Public Health and Information Sciences, University of Louisville, KY, USA, s0kim023@louisville.edu

Journal of Pharmacokinetics and Pharmacodynamics
|July 1, 2011
PubMed
Summary
This summary is machine-generated.

This study introduces P-NONMEM, a novel global search algorithm combining particle swarm optimization (PSO) and NONMEM for population pharmacokinetics/pharmacodynamics (PK/PD) analysis. P-NONMEM improves convergence for nonlinear mixed-effects models, even with distant initial values.

Related Experiment Videos

Area of Science:

  • Pharmacometrics
  • Computational Biology
  • Statistical Modeling

Background:

  • NONMEM is a standard for population PK/PD analysis using nonlinear mixed-effects models.
  • NONMEM's local optimization requires initial values near the global optimum, limiting its effectiveness.
  • Global optimization is crucial for robust parameter estimation in complex models.

Purpose of the Study:

  • To develop a novel global search algorithm, P-NONMEM, for nonlinear mixed-effects models.
  • To enhance the convergence performance of population PK/PD analyses.
  • To ensure global optimization for fixed and variance parameters, and potentially random effects.

Main Methods:

  • P-NONMEM integrates Particle Swarm Optimization (PSO) for global search with NONMEM's local estimation.
  • PSO generates random initial values (particles) for NONMEM.
  • NONMEM is applied to each particle to find local optima for fixed and variance parameters.

Main Results:

  • P-NONMEM demonstrated significantly improved convergence performance compared to standard NONMEM in simulations.
  • The algorithm successfully converged for all parameters (fixed effects, random effects, variance components) even with poor initial values.
  • P-NONMEM achieves global optimization for fixed and variance parameters under regularity conditions.

Conclusions:

  • P-NONMEM offers a robust and computationally efficient approach for population PK/PD analysis.
  • This method overcomes limitations of local optimization algorithms like NONMEM.
  • P-NONMEM provides reliable parameter estimation for nonlinear mixed-effects models in pharmacometrics.